AI ENRICH - AI Detection of ICH
Primary Purpose
Intracerebral Hemorrhage
Status
Enrolling by invitation
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Viz RECRUIT
Sponsored by
About this trial
This is an interventional health services research trial for Intracerebral Hemorrhage focused on measuring Artificial Intelligence, ICH
Eligibility Criteria
Inclusion Criteria:
- Subjects with stroke symptoms who undergo CT brain imaging.
Exclusion Criteria:
- Subjects with poor or incomplete CT brain imaging.
Sites / Locations
- UAMS Medical Center
- Northshore University Health System
- Cooper University Hospital
- Montefiore Medical Center
- SUNY Buffalo
- Geisinger Medical Center
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
No Intervention
Arm Label
Intervention Arm
Control Arm
Arm Description
Subject CT images assessed by Viz RECRUIT software in "real time" analysis All subjects in which the Viz RECRUIT software is utilized will be identified per cohort described below per PI confirmation of ENRICH Trial status/Study ID. Cohort A: Subjects with imaging data Cohort B: Subjects with imaging data and ultimately enrolled as part of the ENRICH Trial
Subjects enrolled as part of the ENRICH Trial prior to Viz RECRUIT software activation
Outcomes
Primary Outcome Measures
Performance
Rate of concordance of Viz RECRUIT software identification of ICH via Head CT images and standard of care radiologist identification of ICH.
Secondary Outcome Measures
Full Information
NCT ID
NCT03865979
First Posted
March 4, 2019
Last Updated
April 26, 2022
Sponsor
Viz.ai, Inc.
Collaborators
Nico Corporation
1. Study Identification
Unique Protocol Identification Number
NCT03865979
Brief Title
AI ENRICH - AI Detection of ICH
Official Title
Automated Detection, Characterization, Triage, and Recruitment of ICH Subjects Using Artificial Intelligence in the ENRICH Trial
Study Type
Interventional
2. Study Status
Record Verification Date
April 2022
Overall Recruitment Status
Enrolling by invitation
Study Start Date
January 23, 2020 (Actual)
Primary Completion Date
December 2022 (Anticipated)
Study Completion Date
December 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Viz.ai, Inc.
Collaborators
Nico Corporation
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Device Product Not Approved or Cleared by U.S. FDA
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
To evaluate the performance of the Viz RECRUIT software in subjects identified as symptomatic of a stroke event as determined by standard of care imaging assessments and interpretation.
Detailed Description
This study will be a multicenter prospective feasibility trial to evaluate the performance of the Viz RECRUIT software. This study will enroll subjects evaluated at each center for stroke via CT imaging. The Viz RECRUIT software will review the CT and notify a specialist if an ICH is detected. It will also evaluate the ICH parameters per study specific guidelines related to the ENRICH Trial and notify a specialist if their ICH meets the study inclusion or exclusion criteria related to cerebral blood flow volume. If an enrolled subject is ultimately included in the ENRICH trial, they will be identified in a prospective cohort of subjects exposed to Viz (intervention arm) will be evaluated per the secondary endpoints to a cohort of subjects retrospectively from the ENRICH Trial (control arm) which were evaluated and enrolled prior to Viz use.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Intracerebral Hemorrhage
Keywords
Artificial Intelligence, ICH
7. Study Design
Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
5000 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Intervention Arm
Arm Type
Active Comparator
Arm Description
Subject CT images assessed by Viz RECRUIT software in "real time" analysis All subjects in which the Viz RECRUIT software is utilized will be identified per cohort described below per PI confirmation of ENRICH Trial status/Study ID.
Cohort A: Subjects with imaging data Cohort B: Subjects with imaging data and ultimately enrolled as part of the ENRICH Trial
Arm Title
Control Arm
Arm Type
No Intervention
Arm Description
Subjects enrolled as part of the ENRICH Trial prior to Viz RECRUIT software activation
Intervention Type
Device
Intervention Name(s)
Viz RECRUIT
Intervention Description
Viz RECRUIT includes the following modules: Viz ICH, Viz VOLUME, Viz VIEW and Viz HUB
Primary Outcome Measure Information:
Title
Performance
Description
Rate of concordance of Viz RECRUIT software identification of ICH via Head CT images and standard of care radiologist identification of ICH.
Time Frame
Enrollment
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Subjects with stroke symptoms who undergo CT brain imaging.
Exclusion Criteria:
Subjects with poor or incomplete CT brain imaging.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Brian T Jankowitz, MD
Organizational Affiliation
The Cooper Health System
Official's Role
Principal Investigator
Facility Information:
Facility Name
UAMS Medical Center
City
Little Rock
State/Province
Arkansas
ZIP/Postal Code
72205
Country
United States
Facility Name
Northshore University Health System
City
Evanston
State/Province
Illinois
ZIP/Postal Code
60201
Country
United States
Facility Name
Cooper University Hospital
City
Camden
State/Province
New Jersey
ZIP/Postal Code
08103
Country
United States
Facility Name
Montefiore Medical Center
City
Bronx
State/Province
New York
ZIP/Postal Code
10467
Country
United States
Facility Name
SUNY Buffalo
City
Buffalo
State/Province
New York
ZIP/Postal Code
14203
Country
United States
Facility Name
Geisinger Medical Center
City
Danville
State/Province
Pennsylvania
ZIP/Postal Code
17822
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
AI ENRICH - AI Detection of ICH
We'll reach out to this number within 24 hrs